Year: 2020

Man Group PLC : Form 8.3 – CPL Resources plc

Written by Customer Service on November 20, 2020. Posted in Mergers And Acquisitions.

Ap19FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATIONINTERESTS AND SHORT POSITIONS Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)Ap20DEALINGS (Note 4) Purchases and sales(b) Derivatives transactions (other than options transactions)(c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varying(ii) Exercising(d) Other dealings (including transactions in respect of new securities) (Note 4)Ap212. OTHER INFORMATIONAgreements,...

Ebix Declares 7.5 Cent Quarterly Dividend, Payable December 15, 2020, to Shareholders of Record December 1, 2020

Written by Customer Service on November 20, 2020. Posted in Dividend Reports And Estimates.

JOHNS CREEK, Ga., Nov. 20, 2020 (GLOBE NEWSWIRE) — Ebix, Inc., (NASDAQ: EBIX) a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries, today announced that its Board of Directors has declared a regular quarterly dividend of 7.5 cents per common share. The dividend is payable December 15, 2020 to shareholders of record at the close of business on December 1, 2020.About Ebix, Inc.With 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing Software-as-a-Service...

Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action

Written by Customer Service on November 20, 2020. Posted in Public Companies.

NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 20, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today announced positive in vitro data by its joint venture partner NLC Pharma for the Company’s dietary supplement Tollovid™, demonstrating its ability to inhibit the 3CL protease. The 3CL protease is an enzyme that is required for the intracellular replication of coronaviruses. Tollovid received a certificate of free sale from the FDA in August 2020 and is being launched commercially into the US market initially at botanical wellness store The Alchemist’s Kitchen™ in New York City.As part of NLC Pharma’s...

Destination XL Group, Inc. Reports Third Quarter Financial Results

Written by Customer Service on November 20, 2020. Posted in Earnings Releases And Operating Results.

CANTON, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the largest omni-channel specialty retailer of big and tall men’s clothing, today reported operating results for the third quarter of fiscal 2020 and provided a business update with respect to the COVID-19 pandemic.Third Quarter Financial HighlightsTotal sales for the third quarter were $85.2 million, down 20.1% from $106.6 million in the prior-year third quarter.Cash Flow from operations for the first nine months of ($8.6) million as compared to the prior year of $(14.4) million. Free Cash Flow was ($11.6) million as compared to ($25.4) million last year.Net loss for the third quarter was $(7.0) million as compared to a net loss of $(7.2) million in the prior year’s third quarter.Adjusted EBITDA for the third quarter was $(1.7) million...

Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine

Written by Customer Service on November 20, 2020. Posted in Public Companies.

In addition to today’s submission to the FDA, the companies have already initiated rolling submissions across the globe including in Australia, Canada, Europe, Japan and the U.K., and plan to submit applications immediately to other regulatory agencies around the worldBased on current projections, the companies expect to produce globally up to 50 million doses in 2020 and up to 1.3 billion doses by the end of 2021; the companies will be ready to distribute the vaccine within hours after authorizationBNT162b2 demonstrated a vaccine efficacy rate of 95%, with no serious safety concerns observed to dateNEW YORK and MAINZ, GERMANY, November 20, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their...

Pfizer und BioNTech reichen Antrag auf Notfallzulassung für COVID-19-Impfstoff bei der U.S. FDA ein

Written by Customer Service on November 20, 2020. Posted in Public Companies.

Neben der heutigen Einreichung bei der FDA haben die Unternehmen bereits eine rollierende Einreichung für den Review-Prozess bei Behörden weltweit gestartet, einschließlich Australien, Kanada, Europa, Japan sowie dem Vereinigten Königreich; weitere Anträge bei anderen Zulassungsbehörden sind in Kürze geplantDie Unternehmen gehen derzeit davon aus, weltweit bis zu 50 Millionen Impfstoffdosen im Jahr 2020 zu produzieren sowie bis zu 1,3 Milliarden Dosen bis Ende 2021; die Unternehmen werden innerhalb weniger Stunden nach der Erteilung der Zulassung für die Impfstoffauslieferung bereit seinBNT162b2 zeigte einen 95 %igen Impfschutz; bislang wurden keine schwerwiegenden Nebenwirkungen festgestelltNEW YORK, USA und MAINZ, Deutschland, 20. November 2020 — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) reichen heute einen...

Armstrong World Industries, Inc. to Acquire Arktura

Written by Customer Service on November 20, 2020. Posted in Public Companies.

LANCASTER, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) — Armstrong World Industries, Inc. (NYSE: AWI) today announced it has entered into an agreement to acquire Arktura, LLC, a designer and fabricator of ceilings, walls, partitions and facades based in Los Angeles, California. Founded and led by architects and designers, Arktura is a leader in architectural specialty metal and felt solutions recognized for fusing ingenuity and creativity with leading edge technologies and software to deliver visionary design.“The Arktura team is widely celebrated for bridging the gap between creative intent and manufacturing capabilities to bring about exceptional ceiling and wall designs for any kind of space,” said AWI CEO Vic Grizzle. “Consistent with our strategy to drive profitable growth, Arktura will help us reach a whole new level of design excellence,...

Clearway Energy, Inc. Signs Binding Agreement to Acquire an Additional 35% Interest in the 290 MW Agua Caliente Solar Project

Written by Customer Service on November 20, 2020. Posted in Public Companies.

PRINCETON, N.J., Nov. 20, 2020 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Company”) today announced that it has entered into an agreement to acquire a 35% interest in the Agua Caliente solar project. Agua Caliente is a 290 MW utility-scale solar project located in Dateland, Arizona in which Clearway currently owns a 16% equity interest. The project has a 25-year PPA with PG&E, with approximately 19 years remaining under the agreement. The Company will acquire the additional 35% interest in Agua Caliente for $202 million, and this acquisition is expected to provide incremental annual asset CAFD on a five-year average basis of $20 million prior to corporate financing.“The additional interest in Agua Caliente is a great addition to the Company’s portfolio,” said Christopher Sotos, Clearway Energy, Inc.’s...

Auction result of Treasury Bonds – RIKB 22 1026 – RIKS 26 0216

Written by Customer Service on November 20, 2020. Posted in Public Companies.

Series RIKB 22 1026 RIKS 26 0216Settlement Date 11/25/2020 11/25/2020Total Amount Allocated (MM) 0 935All Bids Awarded At (Price / Yield) 0.000 / 0.000 108.250 / -0.075Total Number of Bids Received 0 6Total Amount of All Bids Received (MM) 0 935Total Number of Successful Bids 0 6Number of Bids Allocated in Full 0 6Lowest Price / Highest Yield Allocated 0.000 / 0.000 108.250 / -0.075Highest Price / Lowest Yield Allocated 0.000 / 0.000 108.510 / -0.122Lowest Price / Highest Yield Allocated in Full 0.000 / 0.000 108.250 / -0.075Weighted Average of Successful Bids (Price/Yield) 0.000 / 0.000 108.384 / -0.099Best Bid (Price / Yield) 0.000 / 0.000 108.510 / -0.122Worst Bid (Price / Yield) 0.000 / 0.000 108.250 / -0.075Weighted Average of All Bids Received (Price / Yield) 0.000 / 0.000 108.384 / -0.099Percentage...

Niðurstöður í útboði ríkisbréfa – RIKB 22 1026 – RIKS 26 0216

Written by Customer Service on November 20, 2020. Posted in Public Companies.

Flokkur RIKB 22 1026 RIKS 26 0216Greiðslu-og uppgjörsdagur 25.11.2020 25.11.2020Samþykkt tilboð að nafnverði (m.kr.) 0 935Samþykkt (verð / ávöxtunarkrafa) 0,000 / 0,000 108,250 / -0,075Fjöldi innsendra tilboða 0 6Upphæð móttekinna tilboða að nafnverði (m.kr.) 0 935Fjöldi samþykktra tilboða 0 6Fjöldi samþykktra tilboða úthlutað að fullu 0 6Lægsta úthlutaða verð / Hæsta úthlutaða ávöxtunarkrafa 0,000 / 0,000 108,250 / -0,075Hæsta úthlutaða verð / Lægsta úthlutaða ávöxtunarkrafa 0,000 / 0,000 108,510 / -0,122Lægsta verð / Hæsta ávöxtunarkrafa úthlutað að fullu 0,000 / 0,000 108,250 / -0,075Vegið meðaltal samþykktra tilboða (verð / ávöxtunarkrafa) 0,000 / 0,000 108,384 / -0,099Besta tilboð (verð / ávöxtunarkrafa) 0,000 / 0,000 108,510 / -0,122Versta tilboð (verð / ávöxtunarkrafa) 0,000 / 0,000 108,250 / -0,075Vegið...

Year: 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals